Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Final Results of a Phase II Trial of Belinostat (PXD101) in Patients with Recurrent or Refractory Peripheral or Cutaneous T-Cell Lymphoma Pohlman, B., Advani, R., Duvic, M., Hymes, K. B., Intragumtornchai, T., Lekhakula, A., Shpilberg, O., Lerner, A., Ben-Yehuda, D., Beylot-Barry, M., Hillen, U., Fagerberg, J., Foss, F. M. AMER SOC HEMATOLOGY. 2009: 379
View details for Web of Science ID 000272725801100